Coagulation and Natural Anticoagulants » FVIII/IX

Abstract Number: PB0326

A New Test Set up to Dose Factor VIII Ability to Bind Exogenous VWF

F. Mori¹, C. Genuardo¹, A. Caricasole¹, M. Grimaux², O. Kerleau², O. Mathieu², S. Natelli², T. Hervé³, F. Depasse³, P. Fuligni⁴, A. Juif⁵

Abstract Number: PB0343

An Overview of Patients with Hemophilia A in China: Epidemiology, Disease Severity, and Treatment Strategies

X. Song¹, J. Zhong², F. Xue¹, L. Chen¹, H. Li¹, D. Yuan¹, J. Xie², J. Shi¹, L. Zhang¹, E.Q. Wu², R. Yang¹, Analysis Group, Inc., Beijing, China

Abstract Number: PB0348

Analytical Variability (CV) of One Stage Factor VIII Assay: A Quality Control (QC) Experience. Argentinian Group of Biochemists in Hemophilia

M.D.V. Arias¹, E. Sueldo¹, G. Detarsio²

Abstract Number: PB0339

aPTT Reaction Curves Provide Important Additional Information in Hemophilia Patients

J. Pavic¹, M. Milos², D. Coen Herak², R. Zadro^2,3

Abstract Number: PB0347

B Cell Cytokines in Italian Hemophilia A Patients with Inhibitors

B. Doshi^1,2, G. Castaman³, V. Arruda^1,2

Abstract Number: PB0322

Bleeds and Imaging Scores in Relation to Pharmacokinetics of Coagulation Factor VIII in Chinese Pediatric Patients with Severe Hemophilia A

H. Kun, Z. Chen, G. Li, R. Wu, Y. Zhen, N. Zhang

Abstract Number: PB0324

Comparative Analysis of the Coagulometric and Chromogenic Methods for the Determination of Factor VIII Activity in the Plasma of Patients Suspected with Blood Coagulation Disorders

E. Wojtasinska, J. Rupa-Matysek, P. Dziatkiewicz-Warkocz, M. Kozlowska-Skrzypczak, L. Gil

Abstract Number: PB0319

Comparative Pharmacokinetics of Two Recombinant FVIII Concentrates in Chinese Pediatric Patients with Severe Hemophilia A: A Single-Center Study

K. Huang, R. Wu, Z. Chen, Y. Zhen, X. Wu, G. Li

Abstract Number: PB0344

Detection and Quantification of F8 Inv1 and Inv22 Inversions Using Digital Droplet PCR and Mile-post Assays

E. Manderstedt¹, C. Lind-Halldén¹, A. Lidén¹, R. Ljung², J. Astermark², C. Halldén¹

Abstract Number: PB0350

Development and Performance Characterization of an Automated Chromogenic Assay for Human Factor IX Activity

N. Ramamurthy, S. Duffin, C. Kucharski, Z. Vandertuin, S. Kaushik, M. Morris

Abstract Number: PB0330

Difference Molecular Profiles of Type 1 and 2 Inhibitor Developed in Mild/Moderate Hemophilia A

S. Furukawa^1,2, K. Nogami¹, M. Shima^1,2

Abstract Number: PB0323

Emicizumab Treatment in Pediatric Patients with Hemophilia A without Inhibitors: A Single-Institution Study

M. Mori¹, C. Nagae², Y. Umezawa², A. Sudo², T. Ashikaga², A. Yamashita¹, M. Taki¹

Abstract Number: PB0341

Evaluation of Coagulation FIX Binding to Collagen IV and the Impact on Thrombin Generation

G.B. Morrow¹, M.A. Laffan², N. Curry^1,3

Abstract Number: PB0335

Evaluation of Structurally Altered Protein in Factor VIII Therapeutic Products Using Chromatography on Immobilized von Willebrand Factor

H. Chun, J. Pettersson, S. Shestopal, E. Marakasova, T. Lee, A. Sarafanov

Abstract Number: PB0342

Evaluation of the Effect Emicizumab Neutralizing Antibodies on aPTT Clotting-based Tests Results in Patients Treated with Emicizumab

C. Novembrino¹, M. Boscolo-Anzoletti¹, F. Rossi¹, E. Mancuso¹, S. Shinohara², F. Peyvandi^1,3

Abstract Number: PB0328

FVIII Gene Mutation Analysis and Evaluation of Clinical Data: One Center Result

A. Meral Gunes¹, M. Sezgin Evim¹, B. Baytan¹, T. Atik², S. Güler³

Abstract Number: PB0321

Identification of a Novel “Laminin G” Domain Mutant of Protein S Defective in Binding and Inhibiting FIXa and Unaffected in APC/TFPI Cofactor Activities

S. Chatterjee, V. Pilli, R. Majumder

Abstract Number: PB0329

Identification of Zebrafish Orthologue to Human Factor IX Gene and its Age Dependent Regulation

N. Iyer, A. Al Qaryoute, M. Kancham, P. Jagadeeswaran

Abstract Number: PB0325

Inhibitor Risks Estimation Associated with F9 Genotype Types in Patients with Severe Haemophilia B: Argentine vs EAHAD Database

P. Radic¹, B. Ziegler¹, V. Marchione¹, K. Waisman¹, M.M. Abelleyro¹, M. Williams², D. Neme³, C.D. De Brasi^1,4, L. Rossetti¹

Abstract Number: PB0320

Monitoring and Pharmacodynamic Effect of Eftrenonacog-Alfa (Alprolix®) in Severe Hemophilia B Patients: A Real-Life Study

S. Atsou¹, F. Furlan¹, J. Duchemin¹, S. Ellouze¹, E. Sourdeau¹, A. Launois¹, V. Roussel-Robert², N. Stieltjes², S. Combe², M. Fontenay^1,3, E. Curis^4,5, G. Jourdi^1,6